Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on December 23, 2022 Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on December 16, 2022 Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received an intimation from its Registrar and Transfer Agent - Link Intime India Private Limited regarding issue of duplicate share certificates to the shareholder. Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on December 2, 2022 Fermenta Biotech Ltd - 506414 - Related Party Transactions Under Regulation 23 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In connection with our earlier intimation dated November 11, 2022 regarding the Outcome of the Board Meeting for approval of the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022, and in accordance with Regulation 23 of Listing Regulations, we are enclosing herewith the disclosure of Related Party Transactions for the half year ended September 30, 2022. This information will also be made available at https://fermentabiotech.com/stock-exchange-intimation.php Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Further to our intimation dated November 11, 2022 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2022, we hereby enclose a copy of Earnings Presentation for Quarter 2 / Half Year 1 - Financial Year 2022-2023. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com Fermenta Biotech Ltd - 506414 - Publication Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated November 11, 2022, regarding declaration of Unaudited Financial Results for the quarter and half year ended September 30, 2022, we are enclosing herewith photocopy of the newspaper publications published in Business Standard, Mumbai (English version) on page no. 19 and in Sakal, Mumbai (Marathi version) on page no. 7 dated November 12, 2022 for your reference and record. Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on November 15, 2022 Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We write to inform you that the Board of Directors of the Company at its meeting held on November 11, 2022 has, inter alia, approved the unaudited financial results for the quarter and half year ended September 30, 2022 (Standalone and Consolidated) as enclosed. We are enclosing herewith the Limited Review Report dated November 11, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, S R B C & Co. LLP. Kindly take the above on record. The Board meeting commenced at 11.45 a.m. and concluded at 02.55 p.m. Fermenta Biotech Ltd - 506414 - Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
We write to inform you that the Board of Directors of the Company at its meeting held on November 11, 2022 has, inter alia, approved the unaudited financial results for the quarter and half year ended September 30, 2022 (Standalone and Consolidated) as enclosed. We are enclosing herewith the Limited Review Report dated November 11, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, S R B C & Co. LLP. Kindly take the above on record. The Board meeting commenced at 11.45 a.m. and concluded at 02.55 p.m.